Objective: Although buprenorphine treatment reduces risk of overdose and death in opioid use disorder, most patients discontinue treatment within a few weeks or months. Adverse …
We estimate the effect of health insurance coverage on opioid use disorder treatment utilization and availability by exploiting cross-state variation in effective dates of Medicaid …
Importance The Patient Protection and Affordable Care Act (ACA) permits states to expand Medicaid coverage for most low-income adults to 138% of the federal poverty level and …
DL Leslie, DM Ba, E Agbese, X Xing… - Am J Manag …, 2019 - ajmc.s3.amazonaws.com
OUD affects 2.5 million Americans1 and is prevalent across all age groups and backgrounds. It has contributed to increasing injection drug use as well as the spread of …
Comment 286 www. thelancet. com Vol 391 January 27, 2018 medications and is the most frequently prescribed medication for opioid use disorder globally. 14 However, in the USA …
The US continues to grapple with an escalating epidemic of opioid-related overdose and mortality. State funds, which are the second-largest source of public funding for substance …
Buprenorphine is a treatment medication that decreases mortality risks among people with opioid use disorder (OUD). Despite its efficacy, buprenorphine is underused in the US …
Background While there has been a dramatic increase in prescribing of buprenorphine for the treatment of opioid use disorder in the US, little is known about prescribers' attitudes and …
W Lyu, GL Wehby - Medical care, 2019 - journals.lww.com
Background: Recent studies of the impacts of the Affordable Care Act (ACA) Medicaid expansions on cancer screening use have mostly found insignificant effects. We posit that …